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SUMMARY
Objective: To evaluate frequency, anatomic presentation, and quantities of supernumerary parathyroids 
glands in patients with primary hyperparathyroidism (HPT1) associated with multiple endocrine neopla-
sia type 1 (MEN1), as well as the importance of thymectomy, and the benefits of localizing examinations 
for those glands. Methods: Forty-one patients with hyperparathyroidism associated with MEN1 who un-
derwent parathyroidectomy between 1997 and 2007 were retrospectively studied. The location and num-
ber of supernumerary parathyroids were reviewed, as well as whether cervical ultrasound and parathyroid 
SESTAMIBI scan (MIBI) were useful diagnostic tools. Results: In five patients (12.2%) a supernumerary 
gland was identified. In three of these cases (40%), the glands were near the thyroid gland and were found 
during the procedure. None of the imaging examinations were able to detect supernumerary parathyroids. 
In one case, only the pathologic examination could find a microscopic fifth gland in the thymus. In the last 
case, the supernumerary gland was resected through a sternotomy after a recurrence of hyperparathyroid-
ism, ten years after the initial four-gland parathyroidectomy without thymectomy. MIBI was capable of 
detecting this gland, but only in the recurrent setting. Cervical ultrasound did not detect any supernumer-
ary glands. Conclusion: The frequency of supernumerary parathyroid gland in the HPT1/MEN1 patients 
studied (12.2%) was significant. Surgeons should be aware of the need to search for supernumerary glands 
during neck exploration, besides the thymus. Imaging examinations were not useful in the pre-surgical 
location of these glands, and one case presented a recurrence of hyperparathyroidism.
Keywords: Multiple endocrine neoplasia type 1; primary hyperparathyroidism; parathyroid glands; ul-
trasonography; parathyroidectomy.
RESUMO
Paratireoides supranumerárias em hiperparatireoidismo primário 
associado a neoplasia endócrina múltipla tipo 1 
Objetivo: Avaliação da frequência, da localização anatômica e do número de paratireoides extranumerá-
rias em pacientes com hiperparatireoidismo primário (HPT1) associado a neoplasia endócrina múltipla 
tipo 1(NEM1), além da avaliação da importância da timectomia e da utilidade dos exames radiológicos 
para localização destes. Métodos: Foram avaliados de forma retrospectiva 41 pacientes portadores de 
NEM1 com HPT1 submetidos a paratireoidectomia entre 1997 e 2007. O número de glândulas supranu-
merárias encontradas e a sua localização foram revisados, assim como a utilidade do ultrassom cervical 
e do SESTAMIBI (MIBI) de paratireoide como ferramentas diagnósticas. Resultados: Em cinco pacien-
tes (12,2%) foram identificadas glândulas supranumerárias. Em três destes (40%), as glândulas estavam 
próximas à glândula tireoide e foram encontradas durante a exploração cirúrgica. Os exames de imagem 
não foram úteis para a localização destas glândulas. Em um caso, apenas o exame anatomopatológico foi 
capaz de encontrar uma glândula extranumerária microscópica localizada no timo. No último caso, uma 
quinta glândula foi ressecada por meio de esternotomia após a recidiva do hiperparatireoidismo, cerca 
de 10 anos após a paratireoidectomia realizada sem timectomia na ocasião. Neste caso o MIBI detectou 
esta paratireoide apenas após a recidiva da doença. Em nenhum dos casos o ultrassom cervical foi capaz 
de detectar glândulas extranumerárias. Conclusão: A frequência de paratireoides supranumerárias em 
nossa casuística foi significativa (12,2%). Durante a exploração cervical, o cirurgião deve estar atento para 
localizar glândulas extranumerárias além do timo. Exames de imagem não foram úteis na localização pré- 
operatória dessas glândulas, e em um caso houve recidiva do hiperparatireoidismo. 
Unitermos: Hiperparatireoidismo primário; paratireoidectomia; ultrassom; neoplasia endócrina múlti-
pla tipo 1; glândulas paratireoides.
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INTRODUCTION
Multiple endocrine neoplasia type 1 (MEN1) is an autoso-
mal dominant disorder characterized by a germline muta-
tion in the MEN1 gene that causes neoplastic changes in 
several endocrine glands, such as pituitary, pancreatic islet 
cells, and parathyroids1,2. Primary hyperparathyroidism 
(HPT1), an endocrine disturbance where an overproduc-
tion of parathyroid hormone (PTH) leads to elevated se-
rum calcium, is usually the first manifestation of MEN11,3. 
Most cases of HPT1 are sporadic (90%), but there are 
also some familial hereditary syndromes (10%), such as 
MEN1. Single parathyroid adenoma (85%) is the main 
cause of sporadic HPT1, while HPT1 with MEN1 gener-
ally presents an asymmetric parathyroid gland hyperpla-
sia3,4. Parathyroidectomy is the treatment of the disease. 
Many authors recommend partial parathyroidectomy, in 
which part of or one small gland is left in the neck5,6, and 
even selective parathyroidectomy of only abnormal mac-
roscopic glands has been proposed7. Other authors prefer 
total parathyroidectomy with forearm autografting as the 
procedure of choice8. Irrespective to the type of parathy-
roidectomy, transcervical thymectomy seems to be advis-
able, due to the possibility of carcinoid thymic tumors, an 
extremely rare but aggressive neoplasm, which affects up 
to 8% of individuals with MEN1, being a cause of death in 
these patients with delayed diagnosis3,4. The second reason 
for this procedure is the embryological and anatomic rela-
tion between the inferior parathyroids and the thymus9,10, 
which is a frequent site of ectopic parathyroid glands (up 
to 25% of cases) and possible supernumerary glands, when 
there are more than four parathyroids glands11.  These su-
pernumerary glands are an important cause of recurrent 
and persistent HPT1 after parathyroidectomy in MEN1 
patients11,12. Thus, this study aimed to assess the frequency 
of supernumerary parathyroids in 41 Brazilian MEN1 pa-
tients with HPT1, their clinical importance, and the role of 
the diagnostic methods.
 
METHODS
This retrospective study evaluates the frequency, anatomic 
presentation, and quantities of supernumerary parathy-
roids glands in 41 patients with HTP1 associated with 
MEN1 who underwent parathyroidectomy consecutively 
between 1997 and 2007 at the institution. These cases have 
been studied during the screening program for MEN1 that 
is being currently performed in this hospital13,14. They were 
diagnosed with MEN1 as they presented the proband with 
at least two of three tumors or with genetic tests in relatives 
of those patients, in accordance with international guide-
lines15. Whether the imaging examinations, namely cervi-
cal ultrasonography (USG) and parathyroid SESTAMIBI 
scan (MIBI), were effective to detect supernumary glands 
was reviewed. Whether prophylactic thymectomy could 
detect these glands was also studied.
Data collection on the patients’ records searched the 
following parameters: age, gender, surgical procedure, and 
USG and MIBI reports. If available, these examinations 
images were compared with the macroscopic intra-oper-
ative findings, such as  number, size, and location of the 
excised glands. The results of imaging were also analyzed 
when the glands were detected only in the routine histo-
logical examination of the thymus.
RESULTS
Forty-one HTP1/MEN1 patients were operated. Nineteen 
were male and 22 were female. Their ages ranged from 19 
to 73 years, with an average of 40.7 years.
In five patients (12.2%), a fifth parathyroid gland was 
found, and no patient presented more than five glands. Of 
these, only one patient was male and four patients were 
female. Their average age was 44 years (range: 32-59).
In the first case, a 32-year-old female, USG identified 
only one parathyroid gland, and MIBI found two hyper-
active glands. Both findings were not correlated with the 
supernumerary parathyroid. The supernumerary gland 
was located between the upper right and lower right para-
thyroid glands, measuring 0.5 x 0.3 x 0.3 cm. In the second 
case, a female, 57 years old, USG identified only one para-
thyroid, and MIBI showed three hyperactive glands, but 
again none of the results was indicative of the supernumer-
ary gland. The fifth gland was found medially between the 
left parathyroids, measuring 0.9 x 0.9 x 0.6 cm. In the third 
case, a female patient, 40 years old, had the same imaging 
parameters of case 2: only one parathyroid showed by USG 
and three hyperactive parathyroids in MIBI scan. Both ex-
aminations were not correspondent to the intraoperative 
finding of the supernumerary gland, which was just above 
the upper left parathyroid, measuring 0.6 x 0.4 x 0.3 cm. 
In these three cases the supernumerary parathyroids were 
found during the neck exploration, near the thyroid gland. 
In all these cases a clear separation of connective tissue 
was evident with the apparent topic parathyroids, which 
avoided the risk of the misdiagnosis of supernumerary 
gland by surgical splitting.
In the fourth case, a male patient of 59 years, none of 
the imaging studies  or the neck exploration found a super-
numerary gland, but the histological examination of the 
thymus revealed a microscopic supernumerary parathyroid.
The last patient, a 32 years old female, was submitted 
to a total parathyroidectomy with immediate autotrans-
plantation in 1987. At that time, transcervical thymectomy 
was not a routine for these patients and USG was the only 
preoperative imaging available at the institution. Ten years 
after her first surgery (1997), she presented with recurrent 
HPT1. In the preoperative imaging examinations, MIBI 
scan suggested a mediastinal parathyroid gland, which was 
confirmed after resection requiring sternotomy. All cases 
are summarized in Table 1.
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DISCUSSION
Some anatomic studies showed a frequency of supernu-
merary parathyroid glands in the population ranging from 
2.5% to 13%, frequently associated with the thymus or the 
embryological path of the lower parathyroids9,10.
Two studies evaluated cases of supernumerary glands 
in secondary hyperparathyroidism (HPT2). In one study, 
14.3% of patients had a fifth parathyroid16. The other re-
ported supernumerary parathyroids in up to 30% of para-
thyroid operations, and when these glands were not ex-
cised, they were responsible for up to 32% of recurrent and 
persistent HPT217.
Three studies about HTP1 in patients with MEN1 re-
lated different proportions of supernumerary cases: 13%, 
more than 20%, and 30%, respectively12,18,19.
The primary hyperplasia of this study presented an in-
termediary proportion of supernumerary glands in com-
parison to what was published in most anatomic studies 
and in clinical studies of patients with HTP2, and was low-
er than other studies of MEN1, as shown in Table 2. The 
difference between clinical and anatomic studies could be 
explained by the larger size of hyperplastic glands, or by 
the eventuality of its detection in recurrent cases that is not 
possible in cadaveric studies. 
Thompson et al. showed approximately 5% of super-
numerary cases in an anatomical study based on clinical 
cases of HTP1 in general, including single adenomas and 
hyperplasias not related with MEN120. This may be related 
to the fact that the vast majority of cases of solitary HTP1 
are a single adenoma, where the excision of the affected 
gland is sufficient to resolve the disease, avoiding an exten-
sive cervical exploration, reducing the chances of finding 
an extra gland20.
A plausible explanation for a smaller proportion of su-
pernumerary parathyroids in the present study of HPT1 
versus that of HPT2 is the possibility of greater parathyroid 
growth stimulus in HPT2, which normally presents itself 
with more cases of supernumerary glands than general 
HPT120. The clinical or genetic evaluation allows earlier 
diagnosis of HPT1/MEN121,22, which can determine the 
surgical treatment in early phases of HTP1 with less devel-
oped glands, where there was less time for the growth of 
mass and volume of these glands.
Among the 41 patients with HPT1/MEN1 studied, 
only one presented recurrent disease caused by a supernu-
merary parathyroid (2.22%). However, it should be noted 
that many of the present cases have less than ten years of 
follow-up. That is not enough time to rule out the possibil-
ity of recurrence, which occurs very late, in the authors’ 
experience. The recurrence of HPT1 in MEN1 can occur 
later, when compared to HPT2.
The supernumerary parathyroid was found in the thy-
mus in two of five cases. One was identified only through 
histology, and the other through the recurrent HPT1 after 
many years, confirming the possibility of asymmetrical 
and asynchronous hyperplasia of parathyroids in MEN1. 
In this view, studies with less than partial parathyroid-
ectomy in which follow-up is inferior to five to ten years 
should be analyzed with caution. 
The other glands were found during the neck explora-
tion, not far from the other parathyroids. They were in an 
accessible and visible location for the surgeon. Thus, it is 
suggested that any node in the surgical field of the para-
thyroidectomy should be excised and sent for pathology 
testing in patients with MEN1-related HPT1. Irrespective 
to their size or macroscopic aspect, the resection of these 
Patient Gender Age SPT found by USG? SPT found by MIBI? Localization of SPT
1 Female 32 No No Between RSPT and RIPT
2 Female 57 No No Right LSPT and LIPT
3 Male 59 No No Intratimic
4 Female 32 No Ten years after ﬁrst surgery Mediastinal region
5 Female 40 No No Above LSPT
SPT, supernumerary parathyroid; USG, ultrasonography; TPT, topic parathyroid; RSPT, right superior parathyroid; RIPT, right inferior 
parathyroid; LSPT, left superior parathyroid; LIPT, left inferior parathyroid. 
Table 1 – Cases of supernumerary parathyroids
Author / year Proportion 
Akerström G et al.10 / 1984 13% (anatomic)
Wang C9/ 1976 2.5% (anatomic)
Arnalsteen L; Proye C11 / 2003 30% (HTP1/MEN1)
Gomes EMS et al.16 / 2007 14.3% (HTP2)
Lambert LA et al.26 / 2005 2.7% (HTP1)
Pattou FN et al.17 / 2000 30% (HTP2)
Hellman P et al.18 / 1998 > 20% (HTP1/MEN1)
Kraimps JL et al.19 / 1992 13% (HTP1/MEN1)
Present study 12.2% (HTP1/MEN1)
Table 2 – Proportion of supernumerary parathyroids in 
previous studies
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nodes may eventually show a supernumerary parathyroid, 
although in most cases a lymph node is reported by the 
pathologist.
All cases have maintained the location pattern of these 
glands, always reinforcing the need of thymectomy due to 
high incidence, and the need for a careful neck exploration 
during surgery. Arnalsteen et al., in two studies about re-
current HPT1, found that supernumerary parathyroid was 
responsible for 51% of cases recurrent HTP1 in asymmet-
ric hyperplasia, including cases of MEN type 110,11.
As in other studies, in the present study imaging exam-
inations, such as USG and MIBI, were not effective for lo-
calizing supernumerary glands at the initial operation11,16. 
In fact, many supernumerary glands were small and very 
difficult to identify by current methods. The success of 
MIBI scan of hyperactive parathyroids has a close relation-
ship with the size and histological features of these glands, 
but it is useful to suggest an ectopic gland, especially in the 
mediastinal region23-25. One of the present cases, as well as 
a report found in the literature25, may serve as example, 
because ten years after the first surgery, during investiga-
tion of the recurrent disease, only the MIBI scan detected 
the supernumerary parathyroid in the mediastinal region. 
Another method now widely used to detect a possible su-
pernumerary gland is intra-operative serum PTH. This 
method seems to fail in tracking supernumerary glands in 
MEN1, because the PTH secretion ability of a gland de-
pends on its size. Thus, the small size of most supernumer-
ary glands, still in initial hyperplasic process, may prevent 
the production of PTH in sufficient quantity in order to 
affect the pattern of PTH decay8. Notwithstanding, it is 
thought that intraoperative PTH should be employed in 
these cases if available. Intraoperative PTH can suggest a 
hyperfunctioning parathyroid, but it would not be a reli-
able indicator of microscopic glands. It is hard to predict 
if or when a small thymic parathyroid gland will cause 
recurrent HPT. High rates of recurrence (64% at median 
follow-up of four years) after parathyroidectomy in MEN1 
have been reported26. The persistence of an elevated PTH 
level after successful four-gland resection is strongly sug-
gestive of a hyperactive supernumerary parathyroid gland, 
which should be searched for before closing the wound. 
On the other hand, it would help to stop the extensive ex-
ploration when less than four glands were identified, if a 
significant fall of PTH is demonstrated.
As for the benefit of thymectomy, which is routinely 
performed at this institution for HPT in MEN1 cases since 
1997, despite not being part of this study, it is worth not-
ing that another patient followed at the institution, pre-
viously submitted to a parathyroidectomy without thy-
mectomy, developed a thymic carcinoid tumor, five years 
after the parathyroidectomy. Thymectomy is not routinely 
performed for secondary or tertiary HPT at the institu-
tion. No risk of carcinoid tumor is present in renal cases. 
Anatomic bases for supernumerary glands are apparently 
indistinct regarding MEN1, HPT, and renal HPT. Howev-
er, clinical behavior seems to be not comparable: in the au-
thors’ experience, the recurrence rate is low in renal HPT, 
and in most cases related to autotransplantation. These 
examples illustrate and reinforce the potential benefit of 
thymectomy in all cases of HPT1 associated with MEN1. 
In other conditions, such as renal related hyperplasia, the 
risk of extra surgical time and the potential risk to the in-
nominate vein related to this strategy must be considered.
CONCLUSIONS
Supernumerary parathyroid glands in HPT1 with MEN1 
were found in 12.2% of the present cases. Surgeons must 
be aware of the possibility of also finding these glands in 
the neck during the procedure, although many of them are 
in the thymus. Imaging studies were not helpful in locat-
ing supernumerary glands before the first surgery in HPT1 
with MEN1, but this aspect should not discourage their 
use, as ectopic glands are also a considerable clinical prob-
lem in these patients.
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